Handelsbanken Fonder’s Sana Biotechnology SANA Stock Holding History

Handelsbanken Fonder’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,200	Closed	-$40K	–	1621
2023 Q1	$40K	Hold	12,200	–	–	﹤0.01%	1555
2022 Q4	$48K	Sell	12,200 -1,700	-12%	-$8.31K	﹤0.01%	1548
2022 Q3	$83K	Hold	13,900	–	–	﹤0.01%	1542
2022 Q2	$89K	Hold	13,900	–	–	﹤0.01%	1590
2022 Q1	$115K	Hold	13,900	–	–	﹤0.01%	1682
2021 Q4	$215K	Buy	+13,900	New	+$268K	﹤0.01%	1689

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Handelsbanken Fonder's SANA Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Sana Biotechnology (SANA) in Q2 2023, closing a stake of 12,200 shares — an estimated $40K sold.

Handelsbanken Fonder first reported a position in SANA in Q4 2021 and held it in 6 quarters. The position peaked at $215K in Q4 2021. 123 funds tracked by Wall St. Rank hold SANA as of Q2 2023.

Handelsbanken Fonder reported no remaining Sana Biotechnology position as of Q2 2023 after selling out during the quarter.
Handelsbanken Fonder sold 12,200 Sana Biotechnology shares in Q2 2023, an estimated $40K.
Handelsbanken Fonder first reported a position in Sana Biotechnology in Q4 2021 and held it in 6 quarters.
Handelsbanken Fonder's Sana Biotechnology position peaked at $215K in Q4 2021.
123 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.